Image

Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release

Radiation Therapy for Dupuytren's Contracture Following Non-Surgical Release

Recruiting
45 years and older
All
Phase N/A

Powered by AI

Overview

The goal of this study is to learn about preventing recurrence of Dupuytren's Contracture. The main question it aims to answer are:

• Does targeted radiation therapy decrease recurrence of Dupuytren's contracture after treatment with Collagenase Clostridium Histolyticum?

Participants will undergo:

  • Release of Dupuytren's Contracture after Collagenase Clostridium Histolyticum injection
  • Daily radiation therapy treatment for 5 days followed by 6-8 week rest period and then another course of 5 days of radiation therapy

Description

This is a prospective phase II trial where patients diagnosed with late/advanced stage Dupuytren's Contracture (DC) who undergo successful Collagenase Clostridium Histolyticum (CCH) injection and release will receive a standardized regimen of adjuvant radiotherapy (RT). The study will be powered to assess the outcome in patients undergoing the combination of successful release followed by RT. Patients will be monitored for acute and late toxicities while we evaluate disease recurrence defined as a > 20 degree worsening of contracture in the presence of a palpable cord as compared to within 14 days from CCH injection, or the need for medical/surgical intervention to correct the new or worsening contracture.

Eligibility

Inclusion Criteria:

  • Age 45 or greater with DC
  • Extension deficit >10 degrees
  • Unable to simultaneously place the affected finger and palm flat on a table.
  • Women included in the study will be post-menopausal or using contraception, and a pregnancy test will be performed as standard of care.
  • For patients who are having multiple CCH injections, only the first 2 joints on given hand will be included

Exclusion Criteria:

  • Unsuccessful non-surgical release (> N/1 disease)
  • They develop an open wound during CCH
  • Breast feeding or pregnancy
  • A chronic muscular, neurologic, or neuromuscular disorder affecting the hands.
  • Less than the age of 45
  • They have previously undergone radiation on the hand in which they plan to get CCH injections
  • They are pregnant women, impaired adults or prisoners

Study details
    Dupuytren Contracture

NCT06330545

Dartmouth-Hitchcock Medical Center

15 October 2025

Step 1 Get in touch with the nearest study center
We have submitted the contact information you provided to the research team at {{SITE_NAME}}. A copy of the message has been sent to your email for your records.
Would you like to be notified about other trials? Sign up for Patient Notification Services.
Sign up

Send a message

Enter your contact details to connect with study team

Investigator Avatar

Primary Contact

  Other languages supported:

First name*
Last name*
Email*
Phone number*
Other language

FAQs

Learn more about clinical trials

What is a clinical trial?

A clinical trial is a study designed to test specific interventions or treatments' effectiveness and safety, paving the way for new, innovative healthcare solutions.

Why should I take part in a clinical trial?

Participating in a clinical trial provides early access to potentially effective treatments and directly contributes to the healthcare advancements that benefit us all.

How long does a clinical trial take place?

The duration of clinical trials varies. Some trials last weeks, some years, depending on the phase and intention of the trial.

Do I get compensated for taking part in clinical trials?

Compensation varies per trial. Some offer payment or reimbursement for time and travel, while others may not.

How safe are clinical trials?

Clinical trials follow strict ethical guidelines and protocols to safeguard participants' health. They are closely monitored and safety reviewed regularly.
Add a private note
  • abc Select a piece of text.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.